Feature of the week #159: Group Comparison of Endpoints in Simulx

This video explains group comparison of endpoints in Simulx for clinical trial simulations, highlighting its importance in decision-making. As an example, it compares a new drug to a standard treatment using direct comparison and statistical tests that account for both magnitude and group size for significance. The results provide p-values and trial success rates, aiding in optimal decision-making. It also includes an example with lixoftConnectors to automate selection of optimal sample size, making it a valuable tool for clinical trial design.

Correction: In the video at time 6:12 the test verifies if the test treatment is equivalent to the reference treatment or not. In this case, we cannot say if it is better or worse.